ISHIZUYA; Toshinori
Patent Applications and Registrations
Patent applications and USPTO patent grants for ISHIZUYA; Toshinori.The latest application filed is for "preventive and/or therapeutic and/or aggravation suppressing agent for human arthritis deformans".
- ISHIZUYA; Toshinori - Tokyo JP
- Ishizuya; Toshinori - Shizuoka JP
| Patent | Date |
|---|---|
| Preventive And/or Therapeutic And/or Aggravation Suppressing Agent For Human Arthritis Deformans App 20130012440 - ISHIZUYA; Toshinori ; et al. | 2013-01-10 |
| Preventive And/or Therapeutic And/or Aggravation Suppressing Agent For Human Arthritis Deformans App 20110172154 - ISHIZUYA; Toshinori ; et al. | 2011-07-14 |
| Bicyclic compound Grant 7,582,658 - Miyoshi , et al. September 1, 2 | 2009-09-01 |
| 6-Membered heterocyclic compound and use thereof Grant 7,531,533 - Shoda , et al. May 12, 2 | 2009-05-12 |
| 6-Membered heterocyclic compound and use thereof App 20070060590 - Shoda; Motoshi ; et al. | 2007-03-15 |
| Bicyclic compound App 20060069098 - Miyoshi; Shiro ; et al. | 2006-03-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 